Aptose biosciences stock

Aptose Biosciences - APTO - Stock Price & News | The ... Real time Aptose Biosciences (APTO) stock price quote, stock graph, news & analysis.

APTO Aptose Biosciences Inc — Stock Price and Discussion ... Real-time trade and investing ideas on Aptose Biosciences Inc APTO from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. APS Stock Price | Aptose Biosciences Inc. Stock Quote ... Aptose Biosciences Inc. Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. APTO Stock Forecast - Buy or Sell? Aptose Biosciences Aptose Biosciences gained 0.87% in the last trading day (Friday, 3rd Apr 2020), rising from $5.75 to $5.80 During the day the stock fluctuated 6.64% from a day low at $5.57 to a day high of $5.94. APTO Stock Price Summary 30 day high of the APTO stock price was $8.75 and low was $4.27. 90 day high was $9.25 and low was $4.27. Aptose Biosciences Inc. (APTO) Stock Analysis & News ...

Find the latest Aptose Biosciences, Inc. (APTO) stock quote, history, news and other vital information to help you with your stock trading and investing.

APTO Stock Analysis Overview What this means: Aptose Bioscns (APTO) gets a very positive evaluation from InvestorsObserver's ranking system. An Overall Rank of 81 means that our comprehensive methodology rates Aptose Bioscns above 81% of stocks. NASDAQ: APTO :: Aptose Biosciences Inc. (APTO) Aptose Biosciences Inc. Home; About. Overview; Management Team; Board of Directors; Scientific Advisory Board APTO:NASDAQ CM Stock Quote - Aptose Biosciences Inc ...

APTO | Complete Aptose Biosciences Inc. stock news by MarketWatch. View real- time stock prices and stock quotes for a full financial overview.

Company Name: Aptose Biosciences Inc., Stock Symbol: APTO, Industry: Biotechs, Total Posts: 131, Last Post: 3/15/2020 7:16:09 PM. Aptose Biosciences Inc quote is equal to 6.020 USD at 2020-04-06. Based on our forecasts, a long-term increase is expected, the "APTO" stock price prognosis for  7 Mar 2020 Aptose Biosciences Inc. (APTO) is priced at $8.10 after the most recent trading session. At the very opening of the session, the stock price was  16 Mar 2020 Aptose Biosciences Inc. (Aptose) is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs 

Why Aptose Biosciences Shares Jumped Today | The Motley Fool

13 May 2019 In this BBHIC interview, Aptose Biosciences CEO William Rice discusses the company's two clinical programs. Aptose Biosciences, Inc. (APTO) Stock Price, Quote ... Find the latest Aptose Biosciences, Inc. (APTO) stock quote, history, news and other vital information to help you with your stock trading and investing. APTO Stock Price | Aptose Biosciences Inc. Stock Quote (U ... Aptose Biosciences (APTO) Gets a Buy Rating from Oppenheimer In a report released yesterday, Matthew Biegler from Oppenheimer maintained a Buy rating on Aptose Biosciences (APTO), with a … Aptose Biosciences, Inc. Common Shares (APTO) Stock Quotes ... Aptose Biosciences, Inc. Common Shares (APTO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

APTO Stock Quote - Aptose Biosciences, Inc. Stock Price Today

Nov 06, 2019 · APTO, Aptose Biosciences Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines

APTO:NASDAQ CM Stock Quote - Aptose Biosciences Inc ... Stock analysis for Aptose Biosciences Inc (APTO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. APTO | Aptose Biosciences Inc. Annual Income Statement ... Nov 06, 2019 · Aptose Biosciences Inc. annual stock financials by MarketWatch. View the latest APTO financial statements, income statements and financial ratios. Aptose Biosciences, Inc. (APTO) Stock Forum & Discussion ... Aptose Biosciences initiated with a Buy at Maxim Group; tgt $16 (8.60) Maxim Group initiates APTO with a Buy and price target of $16. Analyst Jason McCarthy commented, "Aptose is developing small